MDM2 and central nervous system cancer: To confirm whether the inhibition of MDM2 increased the expression of BAX and PUMA and decreased that of survivin through the activation of p53, we examined the effects of the knockdown of p53 on BAX, PUMA, and survivin expression in glioma stem cells treated with RG7112.